|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-1-6
|
|
pubmed:abstractText |
Endothelin-1 (ET-1) receptor antagonist is expected to improve the prognosis of patients with heart failure, but the role of the ET(B) receptor in cardiac function and structure is complicated. In the present study the NADPH diaphorase activity and ET-1 content in the failing heart treated with ET(A) or ET(B) receptor antagonist were evaluated in a model of dilated cardiomyopathy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1346-9843
|
|
pubmed:author |
pubmed-author:AkiyoshiKenjiK,
pubmed-author:EshiroKeikoK,
pubmed-author:HayashiTetsuyaT,
pubmed-author:IeshimaMiyukiM,
pubmed-author:KitauraYasushiY,
pubmed-author:MatsumuraYasuoY,
pubmed-author:MoriTatsuhikoT,
pubmed-author:NishidaMasahiroM,
pubmed-author:OkadaYoshikatsuY,
pubmed-author:TakaokaMasanoriM,
pubmed-author:YoshikawaJunichiJ,
pubmed-author:YoshiyamaMinoruM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
69
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
107-13
|
|
pubmed:dateRevised |
2005-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15635213-Animals,
pubmed-meshheading:15635213-Cardiomyopathy, Dilated,
pubmed-meshheading:15635213-Cricetinae,
pubmed-meshheading:15635213-Disease Models, Animal,
pubmed-meshheading:15635213-Heart,
pubmed-meshheading:15635213-Heart Function Tests,
pubmed-meshheading:15635213-Male,
pubmed-meshheading:15635213-Muscle Cells,
pubmed-meshheading:15635213-Myocardium,
pubmed-meshheading:15635213-Pyrrolidines,
pubmed-meshheading:15635213-Receptor, Endothelin B,
pubmed-meshheading:15635213-Ventricular Function, Left
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Selective endothelin ET(B) receptor antagonist improves left ventricular function but exaggerates degeneration of cardiomyocytes in J2N-k hamsters.
|
|
pubmed:affiliation |
Department of Pharmacology, Osaka University of Pharmaceutical Sciences, Osaka, Japan.
|
|
pubmed:publicationType |
Journal Article
|
